AxoGen, Inc. (AXGN)

AxoGen Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	159.01	138.58	127.36	112.3	106.71
Revenue Growth (YoY)	14.74%	8.81%	13.41%	5.24%	27.13%
Cost of Revenue	31.14	24.15	22.93	21.58	17.35
Gross Profit	127.87	114.44	104.43	90.72	89.36
Selling, General & Admin	121	116.99	105.67	96.06	103.26
Research & Development	28.33	27.16	24.18	17.85	17.51
Operating Expenses	149.34	144.14	129.84	113.9	120.77
Operating Income	-21.46	-29.71	-25.42	-23.18	-31.41
Interest Expense / Income	2.84	0.62	1.36	1.05	0.04
Other Expense / Income	-2.58	-1.38	0.21	-0.45	-2.31
Pretax Income	-21.72	-28.95	-26.99	-23.79	-29.14
Net Income	-21.72	-28.95	-26.99	-23.79	-29.14
Shares Outstanding (Basic)	43	42	41	40	39
Shares Outstanding (Diluted)	43	42	41	40	39
Shares Change	1.89%	2.11%	3.12%	1.87%	5.68%
EPS (Basic)	-0.51	-0.69	-0.65	-0.60	-0.74
EPS (Diluted)	-0.51	-0.69	-0.65	-0.60	-0.74
Free Cash Flow	-19.59	-36.14	-41.22	-31.53	-24.54
Free Cash Flow Per Share	-0.46	-0.86	-1.00	-0.79	-0.63
Gross Margin	80.42%	82.58%	81.99%	80.78%	83.74%
Operating Margin	-13.50%	-21.44%	-19.96%	-20.64%	-29.43%
Profit Margin	-13.66%	-20.89%	-21.19%	-21.18%	-27.30%
Free Cash Flow Margin	-12.32%	-26.08%	-32.36%	-28.08%	-22.99%
EBITDA	-13.33	-23.47	-20.89	-19.27	-26.22
EBITDA Margin	-8.38%	-16.94%	-16.40%	-17.16%	-24.57%
Depreciation & Amortization	5.55	4.85	4.74	3.46	2.88
EBIT	-18.88	-28.32	-25.63	-22.73	-29.1
EBIT Margin	-11.87%	-20.44%	-20.12%	-20.24%	-27.26%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).